NDC Code(s) : 51079-128-01, 51079-128-20, 51079-128-08
Packager : Mylan Institutional Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Sulfamethoxazole and TrimethoprimSulfamethoxazole and Trimethoprim TABLET | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
NDC 51079-128-08
Sulfamethoxazole
and Trimethoprim
Tablets, USP
800 mg/160 mg
DOUBLE STRENGTH
Each tablet contains:
Sulfamethoxzole, USP
. . . . 800 mg
Trimethoprim, USP
. . . . 160 mg
Usual Dosage: See accompanying
prescribing information.
Store at 20° to 25°C (68° to 77°F). [See
USP Controlled Room Temperature.]
Protect from light.
Tablet debossed: MP85
Manufactured by:
Mutual Pharmaceutical Company, Inc.
Philadelphia, PA 19124
Manufactured for:
Sun Pharmaceutical Industries, Inc.
Cranbury, NJ 08512
Rx only
S-12145 R1
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.